Nathan Weinstein
Stock Analyst
(0.13)
# 1,525
Out of 4,648 analysts
63
Total ratings
10.2%
Success rate
-30.55%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $2.09 | +3,727.75% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $20 → $15 | $0.92 | +1,530.43% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.60 | +900.00% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $1.20 | +2,816.67% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $1.94 | +209.28% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $2.39 | +1,155.23% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $3.04 | +228.95% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $18.34 | +167.18% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $350 → $10 | $0.46 | +2,055.17% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $3.83 | +56,296.87% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.44 | +1,983.33% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $750 → $600 | $0.79 | +75,849.37% | 2 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.29 | +675.19% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $160 | $13.03 | +1,127.94% | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $30.86 | +81.46% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $1.08 | +2,400.00% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $1.32 | +2,551.52% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.78 | +574.16% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $13.09 | +472.96% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $0.36 | +2,998.59% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $3.22 | +5,490.06% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $0.87 | +933.30% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.59 | +289.97% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.60 | +1,719.08% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $3.45 | +146.38% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $2.09
Upside: +3,727.75%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $20 → $15
Current: $0.92
Upside: +1,530.43%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.60
Upside: +900.00%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $1.20
Upside: +2,816.67%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $1.94
Upside: +209.28%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $2.39
Upside: +1,155.23%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $3.04
Upside: +228.95%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $18.34
Upside: +167.18%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $350 → $10
Current: $0.46
Upside: +2,055.17%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $3.83
Upside: +56,296.87%
Dec 7, 2021
Initiates: Buy
Price Target: $30
Current: $1.44
Upside: +1,983.33%
Nov 15, 2021
Maintains: Buy
Price Target: $750 → $600
Current: $0.79
Upside: +75,849.37%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $1.29
Upside: +675.19%
Sep 22, 2021
Maintains: Buy
Price Target: $180 → $160
Current: $13.03
Upside: +1,127.94%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $30.86
Upside: +81.46%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $1.08
Upside: +2,400.00%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $1.32
Upside: +2,551.52%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.78
Upside: +574.16%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $13.09
Upside: +472.96%
Oct 19, 2020
Maintains: Buy
Price Target: $13 → $11
Current: $0.36
Upside: +2,998.59%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $3.22
Upside: +5,490.06%
Aug 3, 2020
Maintains: Buy
Price Target: $13 → $9
Current: $0.87
Upside: +933.30%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $3.59
Upside: +289.97%
May 4, 2020
Maintains: Buy
Price Target: $9 → $11
Current: $0.60
Upside: +1,719.08%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $3.45
Upside: +146.38%